PDT Partners’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$626K Sell
42,100
-42,600
-50% -$459K 0.03% 374
2026
Q1
$717K Hold
84,700
0.04% 375
2025
Q4
$956K Buy
+84,700
New +$1.05M 0.06% 349
2025
Q3
Sell
-27,800
Closed -$392K 587
2025
Q2
$392K Buy
+27,800
New +$495K 0.02% 555
2024
Q1
Sell
-6,931
Closed -$297K 627
2023
Q4
$297K Buy
+6,931
New +$216K 0.03% 466
2023
Q3
Sell
-34,658
Closed -$829K 588
2023
Q2
$829K Sell
34,658
-24,520
-41% -$422K 0.11% 292
2023
Q1
$808K Buy
+59,178
New +$942K 0.11% 307

Other funds holding BHVN

PDT Partners's BHVN Position: Q2 2026 in Review

PDT Partners reduced its Biohaven (BHVN) stake by 50% in Q2 2026, selling an estimated $459K and leaving 42,100 shares worth $626K. The position accounts for 0.03% of the portfolio, ranked #374.

PDT Partners first reported a position in BHVN in Q1 2023 and has held it in 7 quarters since. The position peaked at $956K in Q4 2025. 296 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • PDT Partners held 42,100 shares of Biohaven worth $626K as of Q2 2026.
  • PDT Partners sold 42,600 Biohaven shares in Q2 2026, an estimated $459K.
  • Biohaven made up 0.03% of PDT Partners's portfolio in Q2 2026, its #374 holding.
  • PDT Partners first reported a position in Biohaven in Q1 2023 and has held it in 7 quarters since.
  • PDT Partners's Biohaven position peaked at $956K in Q4 2025.
  • 296 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on PDT Partners's 13F filing for Q2 2026, filed 14 Aug 2026.